Butterfly Network (BFLY) Preferred Stock Liabilities (2019 - 2020)
Butterfly Network recorded quarterly Preferred Stock Liabilities of $360.9 million in Q4 2020, little changed quarter-over-quarter from $360.9 million in Q3 2020, and little changed year-over-year from $360.9 million in Q1 2020.
Butterfly Network's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $360.9 million for Q4 2020.
- In Q4 2020, Preferred Stock Liabilities changed 0.0% year-over-year to $360.9 million; the TTM figure through Dec 2020 stood at $360.9 million (changed 0.0% YoY), while the FY2020 annual figure was $360.9 million, changed 0.0% from the prior year.
- Preferred Stock Liabilities came in at $360.9 million for Q4 2020 at Butterfly Network, roughly flat from $360.9 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $360.9 million in Q4 2019 to a low of $360.9 million in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Butterfly Network | 1.17 Bn | 1.04 Bn | 18.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 360.94 Mn |
| Sep 30, 2020 | 360.94 Mn |
| Jun 30, 2020 | 360.94 Mn |
| Mar 31, 2020 | 360.94 Mn |
| Dec 31, 2019 | 360.94 Mn |